- Citations, last 5 years
- 0
- Works, last 5 years
- 4
- h-index
- 0
- Scientists listed
- 0
- Grants since 2016
- 2
Grants received
2022–2028 · research · R01
Neoantigen-specific Adoptive T Cell Therapy for Glioblastoma, IND-BB-13135, protocol submitted 04/25/2020
Gary W. Wood · TVAX Biomedical (United States) · funded by U.S. Food and Drug Administration
2022–2028 · research · R01
Neoantigen-specific Adoptive T Cell Therapy for Glioblastoma, IND-BB-13135, protocol submitted 04/25/2020
Gary W. Wood · TVAX Biomedical (United States) · funded by U.S. Food and Drug Administration